Milbank Advised on the Financing for Carlyle and PAI’s Joint Acquisition of Theramex

Milbank LLP advised the financing sources for Carlyle and PAI’s joint acquisition of Theramex, the leading global specialty pharmaceuticals company focused on women’s health, from CVC Capital Partners. 

Theramex was created following the carve-out of a portfolio of women’s health pharma products in 2018, and has subsequently developed into one of the largest specialty pharma platforms dedicated to women and their health. The company now serves more than six million women in 57 countries across EMEA, APAC and South America. With the support of Carlyle and PAI Partners, Theramex will seek to expand its diverse suite of products across existing and adjacent therapeutic areas and accelerate international expansion.

The Milbank team was led by European Leveraged Finance/Capital Markets partners Suhrud Mehta and Sarbajeet Nag and associates Laura Bonamis, Michael Gatter, Tom Neilson, Dave Thomas and Pranahita Srinivas.